Lack of involvement of the kallikrein-kinin system in the depressor effect of alpha-methyldopa in normotensive rats.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  General Pharmacology

• Publication date

  1994-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0306-3623(94)90255-0PMID 7958737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• Long-term control of arterial blood pressure.

  1992cited by this paper
• Studies on kininogen bioassay in human and rat plasma by means of trypsin and guinea pig ileum.

  1986cited by this paper
• Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.

  1986cited by this paper
• The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.

  1984cited by this paper
• Centrally Acting Drugs as a Tool to Study Central Mechanisms of Blood Pressure Control

  1983cited by this paper
• Malignant Hypertension: A Syndrome Accompanied by Plasmatic Diminution of Low and High Molecular Weight Kininogens

  1983cited by this paper
• Isolation and structure of T-kinin.

  1983cited by this paper
• CNS mediation of cardiovascular responses to the intracerebroventricular administration of catecholamines

  1982cited by this paper
• Possible Role of Kinins in Circulatory Homeostasis: State of the Art Review

  1981cited by this paper
• Where are children's blood pressures headed?

  1981cited by this paper
• Role of Kinins in the Acute Antihypertensive Effect of the Converting Enzyme Inhibitor, Captopril

  1981cited by this paper
• Malignant Hypertension: A Syndrome Associated with Low Plasma Kininogen and Kinin Potentiating Factor

  1981cited by this paper
• The Antihypertensive Effect of Captopril

  1980cited by this paper
• Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein.

  1979cited by this paper
• Bradykinin, Kallidin, and Kallikreins

  1979cited by this paper
• An improved method for determination of the total kininogen in rabbit and human plasma.

  1978cited by this paper
• An improved method for determination of the total kininogen in rabbit and human plasma.

  1978cited by this paper
• Linking the kallikrein and renin systems via activation of inactive renin: new data and a hypothesis.

  1978cited by this paper
• Pharmacological Effects of α ‐Methyldopa, Alpha‐Methylnorepinephrine, and Octopamine on Rat Arteriolar, Arterial, and Terminal Vascular Smooth Muscle

  1975cited by this paper
• Cardiovascular Regulation by Central Adrenergic Mechanisms and Its Alteration by Hypotensive Drugs

  1975cited by this paper
• Acute Effects of Alpha‐Methyldopa on Mean Blood Pressure and Plasma Renin Activity

  1974cited by this paper
• LOWERING OF KININOGEN IN RAT BLOOD BY ADRENALINE AND ITS INHIBITION BY SYMPATHOLYTIC AGENTS, HEPARIN AND ASPIRIN

  1974cited by this paper
• STUDIES ON THE MECHANISM OF RENIN SUPPRESSION BY ALPHA-METHYLDOPA

  1972cited by this paper
• Fibrinolytic activity evoked in the plasma of the normal and adrenalectomized rat by cellulose sulphate

  1972cited by this paper
• Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline

  1971cited by this paper
• Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats

  1970cited by this paper
• Bradykinin, Kallidin and Kallikrein

  1970cited by this paper
• Central hypotensive effect of alpha-methyldopa.

  1968cited by this paper
• Central hypotensive effect of α‐methyldopa

  1967cited by this paper
• Autonomic nervous system: newer mechanisms of adrenergic blockade.

  1966cited by this paper
• Central regulation of blood pressure.

  1966cited by this paper
• A MICROMETHOD FOR DETERMINATION OF BRADYKININOGEN UNDER SEVERAL CONDITIONS *

  1963cited by this paper
• Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine

  1960cited by this paper
• Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

  1960cited by this paper

• No citing papers are available for this paper.